WeVote
Log In

Bill

Bill

HB 153

AN ACT relating to administrative regulations for medications for substance use disorder and declaring an emergency.

2026 Regular Session Introduced by Chad Aull and 11 co-sponsors

HB 153 expedites Kentucky regulatory changes for substance use disorder medications, potentially expanding or restricting access to medication-assisted treatment options.

to Health Services (H)
#administrativeregulationsandproceedings #drugsandmedicines #effectivedates #emergency #healthandmedicalservices #healthcareprofessionals #nurses #opioids #pharmacists #physicians #publichealth #substanceuse
0
WeVote Research Nonpartisan
Bill Summary · HB 153

Legislative bill overview

HB 153 modifies Kentucky's administrative regulations governing medications used to treat substance use disorders (such as methadone, buprenorphine, and naltrexone). The bill declares an emergency, suggesting expedited implementation of these regulatory changes. The specific regulatory modifications are not detailed in the available information, but the bill addresses how these medications are administered, prescribed, or accessed within the state.

Why this is important

Substance use disorder affects thousands of Kentuckians, and medication-assisted treatment (MAT) is a clinically proven approach to reduce overdose deaths and improve recovery outcomes. Changes to administrative regulations can either expand access to life-saving treatments or create barriers, directly impacting public health outcomes and overdose mortality rates in the state.

Potential points of contention

  • Access vs. oversight balance: Regulations that streamline access may concern those prioritizing strict controls, while stricter regulations may frustrate healthcare providers and patients seeking treatment
  • Emergency declaration justification: The "emergency" designation expedites passage but may limit public comment periods and legislative debate on significant healthcare policy changes
  • Implementation burden: Healthcare providers, pharmacies, and treatment facilities may face compliance costs if regulations increase documentation, training, or operational requirements

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.